2011•Zhongguo yiyuan yongyao pingjia yu fenxiRequires access

Efficacy of Omeprazole Combined Mosapride for Reflux Esophagitis

Hao Li-zhi

Open publisher page 0 citations

Abstract

OBJECTIVE:To evaluate the clinicalefficacyofomeprazole combined mosapride for reflux esophagitis and explore the effective therapy for reflux esophagitis.METHODS:A total of 112 reflux esophagitis cases were equally randomized to either trial group receiving omeprazole plus mosapride or control group.After treatment of 4 weeks,theclinical efficacy and adverse drug reactions in the two groups were recorded.RESULTS:There were statistical significant differences in total effective rate between the two groups after 4-week treatment(P0.05),but the differences in side effects were nonsignificant(P0.05)and the adverse drug reactions were transient.CONCLUSION:Treatment of reflux esophagitiswithomeprazole plus mosapride results in improved clinical efficacy.

About this research paper

What this paper is about

OBJECTIVE:To evaluate the clinicalefficacyofomeprazole combined mosapride for reflux esophagitis and explore the effective therapy for reflux esophagitis.METHODS:A total of 112 reflux esophagitis cases were equally randomized to either trial group receiving omeprazole plus mosapride or control group.After treatment of 4 weeks,theclinical efficacy and adverse drug reactions in the two groups were recorded.RESULTS:There were statistical significant differences in total effective rate between the two groups after 4-week treatment(P0.05),but the differences in side effects were nonsignificant(P0.05)and the adverse drug reactions were transient.CONCLUSION:Treatment of reflux esophagitiswithomeprazole plus mosapride results in improved clinical efficacy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To evaluate the clinicalefficacyofomeprazole combined mosapride for reflux esophagitis and explore the effective therapy for reflux esophagitis.METHODS:A total of 112 reflux esophagitis cases were equally randomized to either trial group receiving omeprazole plus mosapride or control group.After treatment of 4 weeks,theclinical efficacy and adverse drug reactions in the two groups were recorded.RESULTS:There were statistical significant differences in total effective rate between the two groups after 4-week treatment(P0.05),but the differences in side effects were nonsignificant(P0.05)and the adverse drug reactions were transient.CONCLUSION:Treatment of reflux esophagitiswithomeprazole plus mosapride results in improved clinical efficacy.

Key concepts: Mosapride, Reflux esophagitis, Omeprazole, Medicine, Reflux, Gastroenterology, Internal medicine, Esophagitis

Related papers

Back to paper searchBrowse research topicsOriginal source
Efficacy of Omeprazole Combined Mosapride for Reflux Esophagitis — Research Paper | ScholarLens